You are here
Consultations
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Filters
Status
Categories
- Advertising (8) Apply Advertising filter
- Australian Register of Therapeutic Goods (ARTG) (1) Apply Australian Register of Therapeutic Goods (ARTG) filter
- Biologicals (9) Apply Biologicals filter
- Blood and blood components (4) Apply Blood and blood components filter
- Complementary medicines (23) Apply Complementary medicines filter
- Cosmetics (2) Apply Cosmetics filter
- Disinfectants/Sterilants (4) Apply Disinfectants/Sterilants filter
- Import/Export (1) Apply Import/Export filter
- Labelling/Packaging (23) Apply Labelling/Packaging filter
- Legislation (20) Apply Legislation filter
- Listed medicines (2) Apply Listed medicines filter
- Manufacturing (12) Apply Manufacturing filter
- Medical devices safety (1) Apply Medical devices safety filter
- Medical devices/IVDs (49) Apply Medical devices/IVDs filter
- Medicinal cannabis (2) Apply Medicinal cannabis filter
- Medicines (1) Apply Medicines filter
- OTC medicines (32) Apply OTC medicines filter
- Prescription medicines (26) Apply Prescription medicines filter
- Safety of medicines & medical devices (2) Apply Safety of medicines & medical devices filter
- Scheduling (38) Apply Scheduling filter
- Therapeutic Goods Administration (TGA) (6) Apply Therapeutic Goods Administration (TGA) filter
- Therapeutic goods regulation (6) Apply Therapeutic goods regulation filter
Proposed amendments to the Poisons Standard, ACMS meeting, November 2015
Closed on 3 September 2015
Invitation for public comment - ACMS meeting, July 2015
Closed on 9 July 2015
Orphan drugs program
Closed on 15 June 2015
Draft OTC medicine monographs for Bromhexine hydrochloride; Dextromethorphan hydrobromide; Laxatives: Docusate sodium and/or sennosides; Hand sanitisers
Closed on 11 June 2015
Software as a Medical Device (IMDRF Working Group)
Closed on 27 May 2015
Proposed Medicines Advisory Statements Amendment Specification 2015 (corrections and minor changes to the RASML)
Closed on 10 April 2015
TGA adoption of two European Union (EU) scientific guidelines for herbal medicines
Closed on 10 April 2015
Metoclopramide: proposed advisory statements for medicines
Closed on 7 April 2015
Non-steroidal anti-inflammatory drugs (diclofenac, flurbiprofen, ibuprofen, ketoprofen, mefenamic acid and naproxen) for oral use: proposed additional advisory statements for medicines
Closed on 18 March 2015
Regulation of autologous stem cell therapies
Closed on 3 March 2015